13 3 hours ago Healthcare Stocks Small Caps Stocks Cryosite (ASX:CTE) grows EBITDA 27% and now the capacity question takes over Cryosite (ASX:CTE) posts FY26 revenue up 18% to A$16.7m and EBITDA up 27% to A$4.3m as Adderley Street capacity comes online. ByCharlie Youlden